Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Update on Gaucher's disease]

L Virgolini1, F Silvestri, M Baccarani

  • 1Cattedra di Ematologia, Policlinico Universitario, Udine.

Minerva Medica
|March 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of Fitlight training on cognitive-motor performance in élite judo athletes.

Heliyon·2024
Same author

RECURRENT LENTIGO MALIGNA: CONSERVATIVE CONTINUOUS TREATMENT WITH IMIQUIMOD OR REPEATED SURGERY? A LONG-TERM FOLLOW-UP DERMOSCOPIC CASE STUDY.

Experimental oncology·2023
Same author

Introducing clinical nanorachaeaology: Isolation by co-culture of <i>Nanopusillus massiliensis</i> sp. nov.

Current research in microbial sciences·2022
Same author

Scrotal cutaneous metastasis from rectal squamous cell carcinoma: a rare evolution into a rare tumor.

Experimental oncology·2021
Same author

Lasting response after discontinuation of cemiplimab in a patient with locally advanced basal cell carcinoma.

Clinical and experimental dermatology·2021
Same author

Innovation in the solid waste management industry: Integrating neoclassical and complexity theory perspectives.

Waste management (New York, N.Y.)·2020
Same journal

Smoking, healthy lifestyle and adolescence.

Minerva medica·2026
Same journal

How to become a centenarian in four weeks?. Myths and limits of longevity recipes: a critical review.

Minerva medica·2026
Same journal

Comparative efficacy and safety between intravenous recombinant human prourokinase and alteplase in acute ischemic stroke treatment: a meta-analysis of randomized controlled trials.

Minerva medica·2026
Same journal

Efficacy and safety of oral tapentadol for cancer-related pain: an updated systematic review and meta-analysis.

Minerva medica·2026
Same journal

Use of the neurostimulator in thyroidectomy procedures: comparison between vagal and recurrent laryngeal nerve stimulation.

Minerva medica·2026
Same journal

Iron deficiency and risk of acute kidney injury after TAVI: a machine learning analysis.

Minerva medica·2026
See all related articles

Gaucher's disease is a rare genetic lipidosis caused by glucocerebrosidase deficiency. Enzyme replacement therapy shows promising results for managing this lysosomal storage disease.

Area of Science:

  • Biochemistry
  • Genetics
  • Lysosomal Storage Diseases

Context:

  • Gaucher's disease is a lipidosis resulting from glucocerebrosidase deficiency.
  • It leads to glucocerebroside accumulation in macrophage lysosomes.
  • Three autosomal recessive forms exist, with Type I being the most common non-neuronopathic form.

Purpose:

  • To summarize the understanding of Gaucher's disease, its genetic basis, and clinical manifestations.
  • To review current and emerging therapeutic strategies for Gaucher's disease.

Summary:

  • Gaucher's disease involves glucocerebrosidase deficiency and glucocerebroside accumulation.
  • Type I, the most common form, presents with splenomegaly and potential bone pain.
  • Diagnosis relies on enzyme assays, with treatments including splenectomy, bone marrow transplantation, and enzyme replacement therapy.

Related Experiment Videos

Impact:

  • Highlights the clinical variability and diagnostic approaches for Gaucher's disease.
  • Emphasizes the potential of enzyme replacement therapy and ongoing research in gene therapy.